Insulin Intensification for Older Adults with Elevated HbA1c

Basal Insulin Optimization

The American Diabetes Association recommends an HbA1c target of <7.5-8.0% for older adults, and at age 76, this patient likely falls into the "healthy" or "complex/intermediate" category, making aggressive intervention necessary for an HbA1c level of 10.1% 3
Increase glargine from 30 to 40 units at bedtime as the initial step, given the severely elevated HbA1c of 10.1%, and continue titrating glargine by 2-4 units every 3-7 days until fasting glucose consistently reaches 100-130 mg/dL 1, 2

Start aspart 4 units before the largest meal, as this represents 10% of the current basal dose, and increase the prandial dose by 1-2 units twice weekly based on 2-hour postprandial glucose readings 1
The basal-bolus approach is superior to sliding scale insulin alone and results in better glycemic control with lower rates of complications 4

Continue metformin 1,000 mg BID as it provides complementary mechanisms to insulin, helps reduce total daily insulin requirements, and offers cardiovascular benefits 1
Metformin is well-tolerated in older adults unless contraindicated by renal dysfunction (eGFR <30 mL/min) 5

At HbA1c 10.1%, insulin is the most effective glucose-lowering agent, and non-insulin agents alone will not achieve adequate control 1
Prolonged severe hyperglycemia (HbA1c >9%) should be specifically avoided due to increased complication risk 1

In older adults, the risk of severe hypoglycemia increases, particularly with certain medications, and the basal-bolus regimen with insulin analogs has lower rates of severe hypoglycemia compared to NPH or premixed formulations 4, 5
Monitor blood glucose before meals and at bedtime daily during the adjustment period 2

Consider adding a GLP-1 receptor agonist instead of or in addition to prandial insulin if the patient is concerned about weight gain or injection burden 1
Adding an SGLT2 inhibitor could improve glycemic control with lower insulin requirements, weight benefits, and cardiovascular protection, but at HbA1c 10.1%, SGLT2 inhibitors alone would provide insufficient glucose-lowering 1

Do not delay insulin intensification while trying additional oral agents, as this prolongs exposure to severe hyperglycemia and increases complication risk 1
Do not rely solely on sliding scale insulin without optimizing basal insulin first, as this approach is ineffective for long-term management 1, 4
Avoid premixed insulin formulations in older adults, as they are associated with a threefold higher rate of hypoglycemia compared to basal-bolus regimens with insulin analogs 4

With appropriate basal insulin optimization alone, expect HbA1c reduction, and adding prandial insulin should provide an additional reduction, potentially bringing HbA1c to the target range 1
Reassess glycemic control every 2-3 months with monitoring for hypoglycemia and weight changes 1